n-nitrosoiminodiacetic acid has been researched along with buprenorphine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costello, E; Novo, P; Nunes, EV; Rotrosen, J; Shulman, M; Weiss, R | 1 |
| Botbyl, JD; Campbell, ANC; Luderer, HF; Maricich, YA; Nunes, EV | 1 |
| Kropp, FB; Lofwall, MR; Martin, PR; Murphy, SM; Smid, MC; Wachman, EM; Wilder, CM; Winhusen, TJ | 1 |
1 review(s) available for n-nitrosoiminodiacetic acid and buprenorphine
| Article | Year |
|---|---|
Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Naltrexone; Narcotic Antagonists; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2021 |
2 trial(s) available for n-nitrosoiminodiacetic acid and buprenorphine
| Article | Year |
|---|---|
Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study.
Topics: Buprenorphine; Central Nervous System Stimulants; Cocaine; Humans; Nitrosamines; Opiate Substitution Treatment; Opioid-Related Disorders; Substance-Related Disorders | 2022 |
Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study.
Topics: Buprenorphine; Female; Humans; Mothers; Opiate Substitution Treatment; Opioid-Related Disorders; Postpartum Period; Pregnancy | 2023 |